Pharma
Highest conversion and deal size. Validation documentation is the deciding factor.
Segments
Customer Insights
Which industries enquire, which convert, and which are worth building dedicated content and sales capacity around.
Illustrative demo dataSegments Tracked
0
Best Converting
Pharma
24% enquiry to order
Largest Deal Size
₹0.0 L
Pharma average
Repeat Business Rate
0%
+6.2 pts
Leads by segment
Lead share by segment
Segment scorecard
Conversion, deal value and service potential
| Segment | Leads | Conversion | Avg deal | Repeat | Service potential |
|---|---|---|---|---|---|
| Pharma | 28 | 24% | ₹8.4 L | High | High |
| Healthcare | 22 | 21% | ₹6.9 L | High | High |
| Industrial | 34 | 18% | ₹5.2 L | Medium | High |
| Commercial | 41 | 14% | ₹3.6 L | Medium | Medium |
| Contractors | 26 | 17% | ₹7.1 L | High | Low |
| Consultants | 14 | 12% | ₹3.1 L | Medium | Low |
| Retail | 19 | 9% | ₹1.8 L | Low | Medium |
Healthcare
Long approval cycles, but strong repeat and service revenue once inside a hospital group.
Industrial
Highest enquiry volume. Wins on delivery speed and in-house manufacturing capability.
AI Insight
Pharma and healthcare together produce 50 leads but nearly half the pipeline value. Commercial produces the most enquiries at the lowest conversion — worth serving with self-service content rather than sales engineer time.